Your quote: "The best way to get the stock higher is to continue with the hefty annual dividend hikes". WRONG!!!
The surest way to get the stock higher is to invent important new drugs and to avoid expensive flops such as torecetrapib or delayed drug introductions such as Exubera. The main charter of any drug company is to bring to market important new drugs which PFE doesn't seem be able to do that well,in spite of the billions of dollars that it spends on research every year. I don't think that the return on those research dollars have been very good recently.